aluates Reports

$ 0.0

Automative

Global Pemetrexed Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-19Z10509

Global and United States Pemetrexed Drug Market Report Forecast 2022 2028

BUY CHAPTERS

Global Pemetrexed Drug Market Research Report 2025

Code: QYRE-Auto-19Z10509

Report

September 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

TEVA

Eagle Pharmaceuticals

Apotex

Qilu Pharmaceutical

Eli Lilly and Company

Pemetrexed Drug Market Size

The global market for Pemetrexed Drug was valued at US$ 91.1 million in the year 2024 and is projected to reach a revised size of US$ 129 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Pemetrexed Drug Market

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

Pemetrexed is a chemotherapy drug primarily used for the treatment of certain types of lung cancer and mesothelioma. The global market for Pemetrexed is driven by several factors, including the rising incidence of lung cancer and mesothelioma worldwide. These cancers continue to be major public health concerns, and the demand for effective treatments like Pemetrexed remains high. Additionally, advancements in medical research and technology have led to the development of novel chemotherapy drugs, including Pemetrexed, which have shown promising results in clinical trials. This has further contributed to the demand for Pemetrexed in the global market. Moreover, the increasing healthcare infrastructure and expenditure in emerging economies like China, India, and Brazil have opened up new growth opportunities for Pemetrexed manufacturers. These countries have witnessed a significant rise in the number of cancer cases and are investing in improved healthcare facilities, which is expected to boost the market for Pemetrexed.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pemetrexed Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Drug.

The Pemetrexed Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pemetrexed Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pemetrexed Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pemetrexed Drug Market Report

Report Metric	Details
Report Name	Pemetrexed Drug Market
Accounted market size in year	US$ 91.1 million
Forecasted market size in 2031	US$ 129 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	100 mg lyophilized powder/vial 500 mg lyophilized powder/vial
Segment by Application	Pleural mesothelioma Non-small cell lung cancer
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly and Company, Pfizer, Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pemetrexed Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pemetrexed Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pemetrexed Drug Market growing?

Ans: The Pemetrexed Drug Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Pemetrexed Drug Market size in 2031?

Ans: The Pemetrexed Drug Market size in 2031 will be US$ 129 million.

Who are the main players in the Pemetrexed Drug Market report?

Ans: The main players in the Pemetrexed Drug Market are Eli Lilly and Company, Pfizer, Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical

What are the Application segmentation covered in the Pemetrexed Drug Market report?

Ans: The Applications covered in the Pemetrexed Drug Market report are Pleural mesothelioma, Non-small cell lung cancer

What are the Type segmentation covered in the Pemetrexed Drug Market report?

Ans: The Types covered in the Pemetrexed Drug Market report are 100 mg lyophilized powder/vial, 500 mg lyophilized powder/vial

Recommended Reports

Cancer Drugs

Lung Cancer Therapies

Blood Disorders

1 Pemetrexed Drug Market Overview

1.1 Product Definition

1.2 Pemetrexed Drug by Type

1.2.1 Global Pemetrexed Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 100 mg lyophilized powder/vial

1.2.3 500 mg lyophilized powder/vial

1.3 Pemetrexed Drug by Application

1.3.1 Global Pemetrexed Drug Market Value by Application (2024 VS 2031)

1.3.2 Pleural mesothelioma

1.3.3 Non-small cell lung cancer

1.4 Global Pemetrexed Drug Market Size Estimates and Forecasts

1.4.1 Global Pemetrexed Drug Revenue 2020-2031

1.4.2 Global Pemetrexed Drug Sales 2020-2031

1.4.3 Global Pemetrexed Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pemetrexed Drug Market Competition by Manufacturers

2.1 Global Pemetrexed Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pemetrexed Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pemetrexed Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pemetrexed Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pemetrexed Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pemetrexed Drug, Product Type & Application

2.7 Global Key Manufacturers of Pemetrexed Drug, Date of Enter into This Industry

2.8 Global Pemetrexed Drug Market Competitive Situation and Trends

2.8.1 Global Pemetrexed Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pemetrexed Drug Players Market Share by Revenue

2.8.3 Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pemetrexed Drug Market Scenario by Region

3.1 Global Pemetrexed Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pemetrexed Drug Sales by Region: 2020-2031

3.2.1 Global Pemetrexed Drug Sales by Region: 2020-2025

3.2.2 Global Pemetrexed Drug Sales by Region: 2026-2031

3.3 Global Pemetrexed Drug Revenue by Region: 2020-2031

3.3.1 Global Pemetrexed Drug Revenue by Region: 2020-2025

3.3.2 Global Pemetrexed Drug Revenue by Region: 2026-2031

3.4 North America Pemetrexed Drug Market Facts & Figures by Country

3.4.1 North America Pemetrexed Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pemetrexed Drug Sales by Country (2020-2031)

3.4.3 North America Pemetrexed Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pemetrexed Drug Market Facts & Figures by Country

3.5.1 Europe Pemetrexed Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pemetrexed Drug Sales by Country (2020-2031)

3.5.3 Europe Pemetrexed Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pemetrexed Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Pemetrexed Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pemetrexed Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Pemetrexed Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pemetrexed Drug Market Facts & Figures by Country

3.7.1 Latin America Pemetrexed Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pemetrexed Drug Sales by Country (2020-2031)

3.7.3 Latin America Pemetrexed Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pemetrexed Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Pemetrexed Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pemetrexed Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pemetrexed Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pemetrexed Drug Sales by Type (2020-2031)

4.1.1 Global Pemetrexed Drug Sales by Type (2020-2025)

4.1.2 Global Pemetrexed Drug Sales by Type (2026-2031)

4.1.3 Global Pemetrexed Drug Sales Market Share by Type (2020-2031)

4.2 Global Pemetrexed Drug Revenue by Type (2020-2031)

4.2.1 Global Pemetrexed Drug Revenue by Type (2020-2025)

4.2.2 Global Pemetrexed Drug Revenue by Type (2026-2031)

4.2.3 Global Pemetrexed Drug Revenue Market Share by Type (2020-2031)

4.3 Global Pemetrexed Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pemetrexed Drug Sales by Application (2020-2031)

5.1.1 Global Pemetrexed Drug Sales by Application (2020-2025)

5.1.2 Global Pemetrexed Drug Sales by Application (2026-2031)

5.1.3 Global Pemetrexed Drug Sales Market Share by Application (2020-2031)

5.2 Global Pemetrexed Drug Revenue by Application (2020-2031)

5.2.1 Global Pemetrexed Drug Revenue by Application (2020-2025)

5.2.2 Global Pemetrexed Drug Revenue by Application (2026-2031)

5.2.3 Global Pemetrexed Drug Revenue Market Share by Application (2020-2031)

5.3 Global Pemetrexed Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eli Lilly and Company

6.1.1 Eli Lilly and Company Company Information

6.1.2 Eli Lilly and Company Description and Business Overview

6.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eli Lilly and Company Pemetrexed Drug Product Portfolio

6.1.5 Eli Lilly and Company Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Pemetrexed Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Pemetrexed Drug Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Teva

6.3.1 Teva Company Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Pemetrexed Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Pemetrexed Drug Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Eagle Pharmaceuticals

6.4.1 Eagle Pharmaceuticals Company Information

6.4.2 Eagle Pharmaceuticals Description and Business Overview

6.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eagle Pharmaceuticals Pemetrexed Drug Product Portfolio

6.4.5 Eagle Pharmaceuticals Recent Developments/Updates

6.5 APOTEX

6.5.1 APOTEX Company Information

6.5.2 APOTEX Description and Business Overview

6.5.3 APOTEX Pemetrexed Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 APOTEX Pemetrexed Drug Product Portfolio

6.5.5 APOTEX Recent Developments/Updates

6.6 Qilu Pharmaceutical

6.6.1 Qilu Pharmaceutical Company Information

6.6.2 Qilu Pharmaceutical Description and Business Overview

6.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Qilu Pharmaceutical Pemetrexed Drug Product Portfolio

6.6.5 Qilu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pemetrexed Drug Industry Chain Analysis

7.2 Pemetrexed Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pemetrexed Drug Production Mode & Process Analysis

7.4 Pemetrexed Drug Sales and Marketing

7.4.1 Pemetrexed Drug Sales Channels

7.4.2 Pemetrexed Drug Distributors

7.5 Pemetrexed Drug Customer Analysis

8 Pemetrexed Drug Market Dynamics

8.1 Pemetrexed Drug Industry Trends

8.2 Pemetrexed Drug Market Drivers

8.3 Pemetrexed Drug Market Challenges

8.4 Pemetrexed Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

TEVA

Eagle Pharmaceuticals

Apotex

Qilu Pharmaceutical

Eli Lilly and Company

List of Tables

Table 1. Global Pemetrexed Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pemetrexed Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pemetrexed Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pemetrexed Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pemetrexed Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pemetrexed Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pemetrexed Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pemetrexed Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pemetrexed Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pemetrexed Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pemetrexed Drug, Product Type & Application

Table 12. Global Key Manufacturers of Pemetrexed Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pemetrexed Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pemetrexed Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pemetrexed Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Pemetrexed Drug Sales Market Share by Region (2020-2025)

Table 19. Global Pemetrexed Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Pemetrexed Drug Sales Market Share by Region (2026-2031)

Table 21. Global Pemetrexed Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pemetrexed Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Pemetrexed Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pemetrexed Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Pemetrexed Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pemetrexed Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Pemetrexed Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Pemetrexed Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pemetrexed Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pemetrexed Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pemetrexed Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pemetrexed Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pemetrexed Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pemetrexed Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pemetrexed Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pemetrexed Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pemetrexed Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pemetrexed Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pemetrexed Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pemetrexed Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pemetrexed Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pemetrexed Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pemetrexed Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pemetrexed Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pemetrexed Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pemetrexed Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pemetrexed Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pemetrexed Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pemetrexed Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pemetrexed Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Pemetrexed Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Pemetrexed Drug Sales Market Share by Type (2020-2025)

Table 53. Global Pemetrexed Drug Sales Market Share by Type (2026-2031)

Table 54. Global Pemetrexed Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pemetrexed Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pemetrexed Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Pemetrexed Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Pemetrexed Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Pemetrexed Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Pemetrexed Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Pemetrexed Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Pemetrexed Drug Sales Market Share by Application (2020-2025)

Table 63. Global Pemetrexed Drug Sales Market Share by Application (2026-2031)

Table 64. Global Pemetrexed Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pemetrexed Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pemetrexed Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Pemetrexed Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Pemetrexed Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Pemetrexed Drug Price (USD/Unit) by Application (2026-2031)

Table 70. Eli Lilly and Company Company Information

Table 71. Eli Lilly and Company Description and Business Overview

Table 72. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Eli Lilly and Company Pemetrexed Drug Product

Table 74. Eli Lilly and Company Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Pemetrexed Drug Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Teva Company Information

Table 81. Teva Description and Business Overview

Table 82. Teva Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Teva Pemetrexed Drug Product

Table 84. Teva Recent Developments/Updates

Table 85. Eagle Pharmaceuticals Company Information

Table 86. Eagle Pharmaceuticals Description and Business Overview

Table 87. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Eagle Pharmaceuticals Pemetrexed Drug Product

Table 89. Eagle Pharmaceuticals Recent Developments/Updates

Table 90. APOTEX Company Information

Table 91. APOTEX Description and Business Overview

Table 92. APOTEX Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. APOTEX Pemetrexed Drug Product

Table 94. APOTEX Recent Developments/Updates

Table 95. Qilu Pharmaceutical Company Information

Table 96. Qilu Pharmaceutical Description and Business Overview

Table 97. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Qilu Pharmaceutical Pemetrexed Drug Product

Table 99. Qilu Pharmaceutical Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Pemetrexed Drug Distributors List

Table 103. Pemetrexed Drug Customers List

Table 104. Pemetrexed Drug Market Trends

Table 105. Pemetrexed Drug Market Drivers

Table 106. Pemetrexed Drug Market Challenges

Table 107. Pemetrexed Drug Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pemetrexed Drug

Figure 2. Global Pemetrexed Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pemetrexed Drug Market Share by Type: 2024 & 2031

Figure 4. 100 mg lyophilized powder/vial Product Picture

Figure 5. 500 mg lyophilized powder/vial Product Picture

Figure 6. Global Pemetrexed Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Pemetrexed Drug Market Share by Application: 2024 & 2031

Figure 8. Pleural mesothelioma

Figure 9. Non-small cell lung cancer

Figure 10. Global Pemetrexed Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Pemetrexed Drug Market Size (2020-2031) & (US$ Million)

Figure 12. Global Pemetrexed Drug Sales (2020-2031) & (K Units)

Figure 13. Global Pemetrexed Drug Average Price (USD/Unit) & (2020-2031)

Figure 14. Pemetrexed Drug Report Years Considered

Figure 15. Pemetrexed Drug Sales Share by Manufacturers in 2024

Figure 16. Global Pemetrexed Drug Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Pemetrexed Drug Players: Market Share by Revenue in Pemetrexed Drug in 2024

Figure 18. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Pemetrexed Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Pemetrexed Drug Sales Market Share by Country (2020-2031)

Figure 21. North America Pemetrexed Drug Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Pemetrexed Drug Sales Market Share by Country (2020-2031)

Figure 25. Europe Pemetrexed Drug Revenue Market Share by Country (2020-2031)

Figure 26. Germany Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Pemetrexed Drug Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Pemetrexed Drug Revenue Market Share by Region (2020-2031)

Figure 33. China Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Pemetrexed Drug Sales Market Share by Country (2020-2031)

Figure 44. Latin America Pemetrexed Drug Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Pemetrexed Drug Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Pemetrexed Drug Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E Pemetrexed Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Pemetrexed Drug by Type (2020-2031)

Figure 54. Global Revenue Market Share of Pemetrexed Drug by Type (2020-2031)

Figure 55. Global Pemetrexed Drug Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Pemetrexed Drug by Application (2020-2031)

Figure 57. Global Revenue Market Share of Pemetrexed Drug by Application (2020-2031)

Figure 58. Global Pemetrexed Drug Price (USD/Unit) by Application (2020-2031)

Figure 59. Pemetrexed Drug Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pemetrexed Injection Market Research Report 2025

Methotrexate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pemetrexed Diacid Market Research Report 2024

Global Pemirolast Market Insights Forecast to 2030

Methotrexate Oral Solution Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Methotrexate Market Research Report 2025

Global Platinum based Cancer Drug Market Insights Forecast to 2030

Methotrexate Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nelarabine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Platinum based Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Xatmep Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oxaliplatin Market Research Report 2025

Global Pemetrexed Disodium API Market Research Report 2024

Pharmaceutical Grade Pemetrexed Disodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Selpercatinib Capsules Market Research Report 2024

Global Chemotherapy Induced Thrombocytopenia Drugs Market Research Report 2024

Global Pemetrexed Disodium Heptahydrate Market Research Report 2025

Global Melanoma Drugs Market Insights Forecast to 2030

Global Sintilimab Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions